| Annunziata v Quest Diagnostics Inc. |
| 2015 NY Slip Op 03466 [127 AD3d 630] |
| April 28, 2015 |
| Appellate Division, First Department |
[*1]
| Laura Faustini Annunziata et al.,Appellants, v Quest Diagnostics Incorporated, Respondent, et al.,Defendants. |
Kramer & Dunleavy, LLP, New York (Denise M. Dunleavy of counsel), forappellants.
Furman Kornfeld & Brennan LLP, New York (Thomas Combs of counsel), forrespondent.
Judgment, Supreme Court, Bronx County (Howard H. Sherman, J.), entered June 4,2013, dismissing the complaint as against defendant Quest Diagnostics Incorporated,unanimously affirmed, without costs. Appeal from order, same court and Justice, enteredApril 8, 2013, unanimously dismissed, without costs, as subsumed in the appeal from thejudgment.
The issue before us is whether any claim by plaintiffs against defendant QuestDiagnostics Incorporated is subject to the three-year limitations period governingordinary negligence actions (CPLR 214) as opposed to the 2
Plaintiffs however make additional claims that Quest failed to properly employ aplan for error reduction and failed to adequately implement, maintain or supervise qualityassurance. These claims cannot be distinguished from allegations of medical malpractice.In applying the statute of limitations, courts must look to the reality or essence of a claimrather than its form (see Matter of Paver & Wildfoerster [Catholic High SchoolAssn.], 38 NY2d 669, 674-675 [1976]). The critical factor in distinguishing whetherconduct may be deemed malpractice or ordinary negligence is the nature of the dutyowed to the plaintiff that the defendant allegedly breached (see Spiegel, 66 AD3dat 874; Pacio v FranklinHosp., 63 AD3d 1130, 1132 [2d Dept 2009]). The additional claims put forth inthis case would not be actionable in the absence of the misreading of the tissue sample,the basis of the malpractice claim. All of the regulatory infractions alleged by plaintiffsbear a substantial relationship to the rendition of medical treatment (see e.g. Carter v Isabella GeriatricCtr., Inc., 71 AD3d 443, 444 [1st Dept 2010], citing Weiner v Lenox HillHosp., 88 NY2d 784, 788 [1996]). Rodriguez v Saal (43 AD3d 272 [1st Dept 2007]), whichplaintiffs cite, involves a claim against an organ procurement organization that "did notprovide any type of medical treatment directly to [the] decedent" in that case (id.at 274). Rodriguez is distinguishable because, as plaintiffs conceded below,their [*2]claim that Quest misread the tissue samplesounds in medical malpractice. It necessarily follows from plaintiffs' concession as wellas Spiegel that Quest rendered medical services in this case. Therefore, it cannotbe argued that Quest's duty to plaintiffs stemmed from anything other than its role as amedical services provider. We have considered plaintiffs' remaining arguments and findthem unavailing. Concur—Sweeny, J.P., Renwick, DeGrasse, Clark and Kapnick,JJ.